LncRNA TUG1 promoted viability and associated with gemcitabine resistant in pancreatic ductal adenocarcinoma | |
Fan Yang; Xiaofang Li; Lingjuan Zhang; Lina Cheng; Xiuling Li | |
刊名 | JOURNAL OF PHARMACOLOGICAL SCIENCES |
2018 | |
卷号 | Vol.137 No.2页码:116-121 |
关键词 | LncRNA TUG1 PDAC Oncogenic Gemcitabine resistance |
ISSN号 | 1347-8613 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/5465469 |
专题 | 湖南大学 |
作者单位 | Department of Gastroenterology, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, Zhengzhou 450003, China |
推荐引用方式 GB/T 7714 | Fan Yang,Xiaofang Li,Lingjuan Zhang,et al. LncRNA TUG1 promoted viability and associated with gemcitabine resistant in pancreatic ductal adenocarcinoma[J]. JOURNAL OF PHARMACOLOGICAL SCIENCES,2018,Vol.137 No.2:116-121. |
APA | Fan Yang,Xiaofang Li,Lingjuan Zhang,Lina Cheng,&Xiuling Li.(2018).LncRNA TUG1 promoted viability and associated with gemcitabine resistant in pancreatic ductal adenocarcinoma.JOURNAL OF PHARMACOLOGICAL SCIENCES,Vol.137 No.2,116-121. |
MLA | Fan Yang,et al."LncRNA TUG1 promoted viability and associated with gemcitabine resistant in pancreatic ductal adenocarcinoma".JOURNAL OF PHARMACOLOGICAL SCIENCES Vol.137 No.2(2018):116-121. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论